Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18099
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarahaliou, A.en
dc.contributor.authorKatsouras, C.en
dc.contributor.authorKoulouras, V.en
dc.contributor.authorNikas, D.en
dc.contributor.authorNiokou, D.en
dc.contributor.authorPapadopoulos, G.en
dc.contributor.authorNakos, G.en
dc.contributor.authorSideris, D.en
dc.contributor.authorMichalis, L.en
dc.date.accessioned2015-11-24T18:50:33Z-
dc.date.available2015-11-24T18:50:33Z-
dc.identifier.issn1109-9666-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18099-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectAntioxidants/*administration & dosageen
dc.subjectAscorbic Acid/*administration & dosageen
dc.subjectDeferoxamine/*administration & dosageen
dc.subjectDisease Models, Animalen
dc.subjectDrug Therapy, Combinationen
dc.subjectElectrocardiographyen
dc.subjectHeart Rate/drug effectsen
dc.subjectInfusions, Intravenousen
dc.subjectMyocardial Reperfusion Injury/complications/physiopathologyen
dc.subjectSheepen
dc.subjectSiderophores/administration & dosageen
dc.subjectTachycardia, Ventricular/*drug therapy/etiology/physiopathologyen
dc.subjectTreatment Outcomeen
dc.titleVentricular arrhythmias and antioxidative medication: experimental studyen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/18846922-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2008-
heal.abstractINTRODUCTION: Reperfusion arrhythmias could be due to free radicals, while contraction excitation feedback is the cause of arrhythmias generated by blood pressure elevation (BPE). The aim of this study was to test the antiarrhythmic effects of an antioxidant (vitamin C [vit C], 1.5 g), an iron-binding agent (deferoxamine [Def], 1 g), and their combination in an experimental model of arrhythmia based on these 2 mechanisms. METHODS: Thirty anaesthetised sheep were divided into 4 groups, depending on the infused agent: saline (8 sheep), combination of vit C and Def (8), Def (6), and vit C (8). Induction of ventricular arrhythmias was attempted in all animals using both ischaemia-reperfusion (phase I) and a combination of ischaemia and BPE (phase II). In all cases ischaemia was caused by ligating the left anterior descending coronary artery distally to the origin of the 1st diagonal artery, while reperfusion was achieved by releasing the ligation 45 min later. BPE was achieved by obstructing the ascending aorta or by administering intravenous metaraminol. All agents were infused intravenously for 15 min and their administration was started 30 min after the first ligation. Phases I and II lasted 50 and 20 min, respectively. RESULTS: Ventricular tachycardia/fibrillation (VT/VF) was induced in all animals in the control group (8/8) and in the Def group (6/6). VT/VF appeared in 6/8 of the animals in the vit C group (75%) and in only 3/8 of the animals in the combination therapy group (37.5%). The difference between the combination and control groups was statistically significant (p < 0.03). CONCLUSIONS: The intravenous administration of vit C and Def in combination protects against VT/VF induced by ischaemia-reperfusion and/or BPE. Administration of Def alone does not appear to help, while the action of vit C alone is not clear.en
heal.journalNameHellenic J Cardiolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Sideris-2000-ventricular pre excitation.pdf101.44 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons